SCHEMBL16654730

SCHEMBL16654730

Cc1c(Br)c[nH]c(=O)c1C#C[Si](C)(C)C

nearest known ligand 0.30

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ GSK3B P49841 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22264572 0.75 ATM (0.50) —
SCHEMBL2124039 0.69 DAO (0.37) GSK3B
SCHEMBL4158371 0.68 ERCC1 (0.43) —
SCHEMBL7422492 0.68 DAO (0.35) GSK3B
SCHEMBL1725120 0.66 DAO (0.34) —
SCHEMBL1564773 0.66 TSHR (0.33) —
SCHEMBL30770093 0.65 — —
SCHEMBL16654880 0.65 ALDH1A1 (0.33) —
SCHEMBL16654820 0.65 PKM (0.35) —
SCHEMBL16654461 0.65 DAO (0.42) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3057586-A1 BROMODOMAIN INHIBITORS Celgene Quanticel Research, Inc. (US) 2016-08-24 — — EP disclosed
WO-2015058160-A1 BROMODOMAIN INHIBITORS Quanticel Pharmaceuticals, Inc. (US) 2015-04-23 — — WO disclosed
Send feedback